Action of L- -methyldopa-hydrazine on the blood pressure of patients receiving levodopa

Br J Pharmacol. 1972 Jan;44(1):162-4. doi: 10.1111/j.1476-5381.1972.tb07249.x.

Abstract

The blood pressure and pulse rate have been compared in a 'double blind, cross over' study involving twenty patients with idiopathic Parkinsonism receiving maximum tolerated dosage of levodopa with and without an extracerebral decarboxylase inhibitor, L-alpha-methyldopahydrazine. The supine and erect systolic pressures were significantly higher and the erect pulse rate significantly lower during administration of L-alpha-methyldopahydrazine. The implications of these observations are discussed.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Blood Pressure / drug effects*
  • Dihydroxyphenylalanine / blood
  • Dihydroxyphenylalanine / pharmacology*
  • Dihydroxyphenylalanine / therapeutic use
  • Dopamine / pharmacology
  • Female
  • Humans
  • Hydrazines / pharmacology
  • Hydrazines / therapeutic use
  • Hypotension / chemically induced
  • Male
  • Methyldopa / pharmacology*
  • Methyldopa / therapeutic use
  • Middle Aged
  • Parkinson Disease / drug therapy
  • Pulse / drug effects

Substances

  • Hydrazines
  • Methyldopa
  • Dihydroxyphenylalanine
  • Dopamine